| 2025 | 2024 | 2023 | 2022 | 2021 | 2018 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 517,1 k € | -3.8% | 537,8 k € | +9.0% | 493,4 k € | -8.5% | 539,1 k € | -7.6% | 583,5 k € | -26.3% | 791,8 k € | +2.8% | 770,2 k € | -1.3% | 780,4 k € | -5.8% | 828,2 k € | -6.4% | 884,9 k € | +6.4% | 831,6 k € | -1.3% | 842,3 k € | +19.4% | 705,6 k € | -10.4% | 787,6 k € | +3.6% | 760,1 k € | -3.8% | 789,8 k € | +16.3% | 679,3 k € | |
| EBITDA | 4,2 k € | -44.5% | 7,6 k € | +109.2% | -82,7 k € | -308.7% | -20,2 k € | +27.4% | -27,9 k € | -113.0% | 215,1 k € | -7.2% | 231,8 k € | -4.1% | 241,7 k € | -24.9% | 321,8 k € | -21.9% | 412,2 k € | +17.2% | 351,6 k € | -4.4% | 367,7 k € | +59.1% | 231,1 k € | -16.5% | 276,9 k € | -12.2% | 315,3 k € | -22.6% | 407,1 k € | +22.8% | 331,4 k € | |
| Operating profit | -48,1 k € | -60.9% | -29,9 k € | +74.3% | -116,2 k € | -16.3% | -99,9 k € | +6.7% | -107,1 k € | -208.7% | 98,5 k € | +45.2% | 67,8 k € | -29.6% | 96,3 k € | -62.3% | 255,5 k € | -25.8% | 344,4 k € | +19.0% | 289,5 k € | -12.9% | 332,4 k € | +73.9% | 191,1 k € | -4.9% | 201,0 k € | -3.0% | 207,2 k € | -33.6% | 312,0 k € | +32.5% | 235,4 k € | |
| Profit/loss | 122,7 k € | +7063.6% | -1,8 k € | +97.3% | -64,7 k € | +5.7% | -68,6 k € | -4.5% | -65,6 k € | -811.3% | 9,2 k € | -91.8% | 111,8 k € | -50.0% | 223,8 k € | -3.2% | 231,2 k € | -30.6% | 333,0 k € | +37.1% | 242,8 k € | -6.3% | 259,1 k € | +25.2% | 207,0 k € | +51.7% | 136,4 k € | +71.8% | 79,4 k € | -69.7% | 262,4 k € | +33.5% | 196,5 k € | |
| Equity | 3,3 M € | -1.3% | 3,3 M € | -0.1% | 3,3 M € | -6.4% | 3,6 M € | -1.9% | 3,6 M € | -7.5% | 3,9 M € | +4.6% | 3,8 M € | +1.7% | 3,7 M € | +4.9% | 3,5 M € | +5.4% | 3,3 M € | +9.2% | 3,1 M € | +7.2% | 2,9 M € | +8.4% | 2,6 M € | +6.9% | 2,5 M € | +4.2% | 2,4 M € | +1.8% | 2,3 M € | +10.7% | 2,1 M € | |
| Total assets | 3,6 M € | -4.4% | 3,7 M € | +1.8% | 3,7 M € | -4.8% | 3,8 M € | -5.4% | 4,1 M € | -4.7% | 4,3 M € | -1.2% | 4,3 M € | +0.4% | 4,3 M € | +9.8% | 3,9 M € | +5.8% | 3,7 M € | +8.7% | 3,4 M € | +2.8% | 3,3 M € | +13.1% | 2,9 M € | +7.0% | 2,7 M € | +3.4% | 2,6 M € | +2.4% | 2,6 M € | +12.2% | 2,3 M € | |
| Cash | 191,0 k € | -29.5% | 270,9 k € | -47.1% | 512,5 k € | +9.6% | 467,6 k € | +0.5% | 465,3 k € | +25.3% | 371,3 k € | +27.6% | 290,9 k € | -58.2% | 695,3 k € | +147.0% | 281,5 k € | -1.5% | 285,7 k € | +24.4% | 229,7 k € | -52.9% | 487,5 k € | +85.7% | 262,5 k € | +14.7% | 228,8 k € | +52.6% | 150,0 k € | +167.2% | 56,1 k € | -11.6% | 63,5 k € | |
| Debts | 256,1 k € | -32.1% | 377,4 k € | +22.1% | 309,1 k € | +18.2% | 261,5 k € | -35.9% | 408,3 k € | +28.8% | 316,9 k € | -41.6% | 543,0 k € | -7.7% | 588,2 k € | +55.1% | 379,2 k € | +9.8% | 345,4 k € | +4.0% | 332,0 k € | -25.3% | 444,8 k € | +56.3% | 284,6 k € | +7.9% | 263,8 k € | -3.5% | 273,4 k € | +7.7% | 253,7 k € | +27.5% | 199,0 k € | |
| Staff | 5,5 | 6,6 | 7,1 | 8 | 7,9 | 8,2 | 8,1 | 8,1 | 8,1 | 7,5 | 8,3 | 7,9 | 9 | 9,5 | 8,9 | 8,5 | 8,3 | |||||||||||||||||
Public limited company · Kortrijk · incorporated on 22/04/1982 · 5,5 ETP
Public limited company profitable and well capitalised. Cash position declining (-29.5%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Unifarma is a Public limited company incorporated in 1982. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Kortrijk. It employs on average 5,5 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette